Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Index
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - OptimizeRx (NASDAQ: OPRX)
Follow
NASDAQ:OPRX
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
OPRX
OptimizeRx
Stelmakh Edward
/
officer: CFO/COO
10/11/2022
Sell
$15.17
3,539
$54K
7,682
NASDAQ
OPRX
OptimizeRx
Silvestro Stephen L
/
officer: Chief Commercial Officer
03/01/2024
Sell
$15.95
668
$11K
5,956
NASDAQ
OPRX
OptimizeRx
Odence-Ford Marion
/
officer: General Counsel and CCO
03/01/2024
Sell
$15.95
268
$4K
14,231
NASDAQ
OPRX
OptimizeRx
Besch Doug
/
officer: Chief Product Officer
12/19/2023
Buy
$12.73
5,892
$75K
5,892
NASDAQ
OPRX
OptimizeRx
Odence-Ford Marion
/
officer: General Counsel and CCO
12/19/2023
Buy
$12.73
11,783
$150K
11,783
NASDAQ
OPRX
OptimizeRx
Silvestro Stephen L
/
officer: Chief Commercial Officer
12/19/2023
Buy
$12.73
19,639
$250K
19,639
NASDAQ
OPRX
OptimizeRx
Odence-Ford Marion
/
officer: General Counsel and CCO
02/11/2024
Sell
$15.39
1,386
$21K
13,728
NASDAQ
OPRX
OptimizeRx
FEBBO WILLIAM J
/
director, officer: CEO
01/09/2024
Sell
$13.25
2,884
$38K
478,144
NASDAQ
OPRX
OptimizeRx
Odence-Ford Marion
/
officer: General Counsel and CCO
01/09/2024
Sell
$15.19
4,000
$61K
11,114
NASDAQ
OPRX
OptimizeRx
Odence-Ford Marion
/
officer: General Counsel and CCO
11/08/2023
Sell
$9.21
524
$5K
15,114
NASDAQ
OPRX
OptimizeRx
Greco Theresa
/
officer: Chief Commercial Officer
11/01/2023
Buy
$8.10
35,758
$290K
35,758
NASDAQ
OPRX
OptimizeRx
Stelmakh Edward
/
officer: CFO/COO
10/11/2023
Sell
$7.15
2,066
$15K
29,537
NASDAQ
OPRX
OptimizeRx
Odence-Ford Marion
/
officer: General Counsel and CCO
10/03/2023
Sell
$7.06
1,952
$14K
13,853
NASDAQ
OPRX
OptimizeRx
Silvestro Stephen L
/
officer: Chief Commercial Officer
10/03/2023
Sell
$7.06
1,952
$14K
4,697
NASDAQ
OPRX
OptimizeRx
Stelmakh Edward
/
officer: CFO/COO
10/03/2023
Sell
$7.06
4,117
$29K
17,227
NASDAQ
OPRX
OptimizeRx
Besch Doug
/
officer: Chief Product Officer
10/03/2023
Sell
$7.06
976
$7K
3,848
NASDAQ
OPRX
OptimizeRx
FEBBO WILLIAM J
/
director, officer: CEO
04/18/2023
Buy
$14.42
161,698
$2.332M
161,698
NASDAQ
OPRX
OptimizeRx
Stelmakh Edward
/
officer: CFO/COO
10/11/2022
Sell
$15.17
6,539
$99K
4,682
NASDAQ
OPRX
OptimizeRx
Odence-Ford Marion
/
officer: General Counsel and CCO
03/01/2023
Sell
$18.11
268
$5K
9,156
NASDAQ
OPRX
OptimizeRx
Silvestro Stephen L
/
officer: Chief Commercial Officer
03/01/2023
Sell
$18.11
668
$12K
4,459
NASDAQ
OPRX
OptimizeRx
Inman Todd
/
officer: Chief Technology Officer
03/01/2023
Sell
$18.11
233
$4K
538
NASDAQ
OPRX
OptimizeRx
Odence-Ford Marion
/
officer: General Counsel and CCO
02/11/2023
Sell
$17.34
1,422
$25K
8,653
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science Stock News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2024
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On Twitter
Advertise Your Company
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily Life Science Stock News
Register
or
Login
to Access Entire Platform.